Mealey's (December 5, 2018, 12:36 PM EST) -- LONDON — Diabetes drugs belonging to the sodium glucose cotransporter 2 (SGLT2) class are associated with an increased risk of lower limb amputation and diabetic ketoacidosis (DKA) compared to drugs of the preceding class, known as glucagon-like peptide-1s (GLP1s), according to a cohort study published in the Nov. 14 issue of the British Medical Journal (BMJ 2018; 363:k4365)....